Sekbio's Monkeypox Antigen Rapid Test Kit Achieves FIND Catalog Inclusion
We are proud to announce that our Monkeypox Antigen Rapid Test has been included in the FIND (Foundation for Innovative New Diagnostics) directory.This achievement signifies that our product has been recognized globally for its diagnostic value and quality.
The Monkeypox Antigen Rapid Test is an innovative diagnostic tool designed for the rapid identification of monkeypox virus infections. Since the outbreak of the monkeypox virus in non-endemic countries in 2022, the World Health Organization (WHO) has assessed this outbreak as "atypical." Therefore, establishing a rapid and effective assay is crucial for outbreak prevention and control.
Our test kit utilizes the uniqueness of the monkeypox virus A29 protein, expressed in Escherichia coli BL21, and 25 monoclonal antibodies (mAbs) obtained using mouse hybridoma techniques, to establish an immunochromatographic test strip method. This method has shown the best sensitivity and the lowest detection limit, capable of detecting purified A29 protein at a level as low as 50 pg mL^-1.
Furthermore, our test kit has performed excellently in specificity tests, showing no cross-reactivity with other orthopox viruses (such as vaccinia virus or cowpox virus) and common respiratory pathogens (such as SARS-CoV-2, influenza A, and influenza B).
We look forward to working with global partners to contribute to the fight against the spread of the monkeypox virus by providing high-quality diagnostic tools. For more information or to inquire about how to integrate our Monkeypox Antigen Rapid Test into your detection strategy, please visit our website or contact our sales team directly.
About the FIND Directory:
FIND is an internationally recognized resource that provides independent evaluations and performance data on COVID-19 diagnostic tools for public health decision-makers, procurement agencies, and implementation partners. The inclusion of our Monkeypox Antigen Rapid Test in the directory proves that it meets high standards in terms of sensitivity and specificity.
About Us:
We are committed to providing innovative, reliable, and easy-to-use diagnostic solutions to support disease detection and control efforts worldwide. Our products are designed to help healthcare professionals quickly and accurately diagnose monkeypox virus infections, thereby better managing cases and preventing the spread of the virus.
We look forward to your cooperation and together making a contribution to global health security.
Related Immunoassays
- Cardiac Markers
-
Tumor Marker
-
PGII
-
G17
- CA50
-
CA125
- CA242
-
CA15-3
- CA19-9
- CA72-4
-
Pepsinogens I (PGI)
-
Human Epididymis 4 (HE4)
- Prostate-Specific Antigen (PSA)
- Squamous Cell Carcinoma (SCC)
- Neuron-Specific Enolase (NSE)
- Cytokeratin 19 Fragment (CYFRA21-1)
- Human Progastrin-releasing Peptide (ProGRP Tumor Marker)
- Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA II Tumor Marker)
- Alpha-fetoprotein(AFP)
-
CEA
-
Human Chitinase 3-like 1
-
PGII
- Inflammatory Marker
- Infectious Disease
- Hormones
- Thyroid Function
- Glucose Metabolism
- Bone Marker
- Others
-
Heterophilic Blocking Reagent
- Animal Diagnostics